Citeline Podcasts
av Norstella
Strategic Intent: Praxis CEO On Unlearning, AI And Launching Two…
Om denne podkasten
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Episoder
De 50 nyeste av 649 episoder
- Strategic Intent: Praxis CEO On Unlearning, AI And Launching Two Neuroscience Drugs At Once · 45 minPraxis Precision Medicines is within weeks of FDA decisions on two potential firsts: relutrigine for SCN2A and SCN8A developmental and epileptic encephalopathies, and…
- China Biopharma English-Language Podcast: Does China Reimburse Its Most Innovative Drugs? · 7 minIn this episode of the China biopharma English-language podcast, Xu Hu in Shanghai talks about the insurance coverage of the most innovative drugs approved in China between 2020…
- Drug Fix: US FDA’s CNPV Program Ends, Commissioner Nominee’s Day Of Reckoning Arrives · 33 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and Prevision Policy Founding Member Mike McCaughan consider the lessons…
- Special Episode: Topspin and Why Product Demand, Not Coverage, Drives Formulary Power · 49 minConventional wisdom says you secure coverage first, then build demand. What if the causality runs the other way? In this special In Vivo podcast episode, senior reporter David…
- Strategic Intent: Lundbeck On Reimbursement, Risk And The Return Of Neuroscience · 20 minIn this episode of Strategic Intent, Maria Alfaiate, Executive Vice President for Corporate Portfolio and Product Strategy at Lundbeck, discusses neuroscience's growing…
- Over The Counter: Earning The Pharmacist’s Recommendation, With Thorrun Govind · 27 minWhen a customer asks a pharmacist what to take, brand awareness only gets a product so far. A recommendation has to be earned, says pharmacist, healthcare lawyer and broadcaster…
- 【3分で解説 #世界のファーマ】第32回 民主党逆転の米国中間選挙 製薬業界への影響は?(Japanese-language podcast) · 4 min世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら Democratic Wins In Congress Will Fuel MFN, FDA Oversight…
- Drug Fix: How Will US FDA Navigate Midterm Blue Wave’s Aftermath? · 34 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the potential changes that the midterm election rout by Democrats…
- Proof of Concept: The Money Is Back In RNA, But What Stands Between Headlines And Routine Medicine? · 40 min"The money is back in RNA. In recent weeks, Merck KGaA agreed to pay about $1.1 billion for Silence Therapeutics, Novartis signed a deal worth up to $7.8 billion with Abogen…
- Rethinking Risk: Why Early Evidence Strategy Matters for Emerging Biotechs · 23 minFor emerging biotech companies, development success is often measured by clinical milestones, safety, and efficacy. However, demonstrating an asset’s value extends beyond…
- Drug Fix: Could Other Products Use Peptide Order For Access, Industry Opposes CRL Release · 34 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman and Editor-in-Chief Nielsen Hobbs consider the impact of the Health and Human…
- Strategic Intent: Understanding Crossover Strategies in Biotech With Sofinnova Partners’ David Evans · 30 minIn this episode of Strategic Intent, Partner at Sofinnova Partners, David Evans discusses his transition from Roche Venture Fund, different investments strategies, general market…
- Scrip Awards Podcast – Parabilis CEO Mathai Mammen Interview · 29 minAhead of the awards presentation on Dec 2, the Scrip Awards podcast speaks to Mathai Mammen, CEO of Parabilis, one of the shortlisted companies for Biotech of The Year.
- Strategic Intent: Can Blood Tests Break the Alzheimer’s Diagnosis Bottleneck? · 29 minDisease-modifying Alzheimer’s treatments have arrived, but diagnosing the right patients at scale is still a major bottleneck. In this episode of Strategic Intent, Marion Webb…
- Off-Patent, On Record: Unlocking The Value Of Biosimilars Beyond Savings With IGBA’s Ana Gaunt · 27 minIn the latest episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė talks to the International Generic and Biosimilar medicines Association’s…
- Drug Fix: What Drove US FDA Generics Chief To Step Down And New Rare Disease Framework · 28 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss the reasons Iilun Murphy, director of the US Food and Drug…
- Scrip Chinese-Language Podcast - Oct. 14, 2026 · 18 min本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年10月9日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本周内容包括:中国带来的竞争威胁;第三季度并购活动降温;新型肺炎球菌疫苗竞争者;西班牙生物技术公司的战略;以及盐野义制药20亿美元的收购案。Story links…
- Digital Health Roundup: BD’s $19Bn Tariff Deal, Longevity, GLP-1 Tools Chasing Proof · 18 minIn this month's podcast, Shubham Singh discusses BD’s $19bn US investment deal for tariff relief; Brian Bossetta, NET Recovery’s stimulant-use device; George Underwood, Reset…
- Scrip's Five Must-Know Things - Oct. 13, 2026 · 16 minJoin us for an audio catch-up on the major events in the global biopharma industry over the past week, as reported by Scrip’s global team, in this podcast version of Five…
- Strategic Intent: Celebrity Marketing In The Age Of Promo Crackdown · 27 minCan a celebrity campaign still work for a drug company when the FDA is watching every word? In this episode of Strategic Intent, Frank Watanabe, CEO of Arcutis Biotherapeutics…
- Drug Fix: US FDA’s Peptide Drama, More Transparency, Ibogaine Clinical Trial Plans · 41 minPink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Senior Reporter Maaisha Osman discuss the drama unfolding at the US…
- Off-Patent, On Record: Navigating The Financial Strategy Behind Litigation With Sandoz’s Julia Pike · 24 minIn the third episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė is joined by Sandoz’s head of IP Julia Pike to analyze the European…
- Strategic Intent: Using Agentic AI To Create ‘The Self-Driving Clinical Trial, Kind Of Like The Car’ · 33 minIn this Strategic Intent episode, In Vivo speaks with Ken Getz, executive director of the Tufts CSDD and research professor at the Tufts University School of Medicine, and Pamela…
- Counting Self-Care’s Triple Win, With GSCF’s Greg Perry And Ben Carrick · 56 minThe Global Self-Care Federation has updated its analysis of the health, social and economic value of self-care, using data from 155 countries. Savings to health systems are up…
- Drug Fix: CMS Finalizes GLOBE Model And US FDA Adcomm, Personnel Changes · 31 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Senior Writer Cathy Kelly discuss the limited impact the US Centers for Medicare and Medicaid Services’…
- Proof of Concept - Can AI Outrun the Next Outbreak? · 40 minWhat if you could design a diagnostic and a therapeutic directly from a pathogen's genetic code, faster than the disease can spread? Jared Bauer, co-founder and CEO of Seek Labs…
- 【3分で解説 #世界のファーマ】第31回 中国、バイオ医薬品の成長に本腰 初の5カ年計画 (Japanese-language podcast) Sept. 30, 2026 · 3 min世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら Six Chinese Drugs On Course For Blockbuster Status As…
- Strategic Intent: Boehringer Ingelheim's Brian Hilberdink on Launching Into the GLP-1 Era · 30 minBrian Hilberdink, President of US Human Pharma at Boehringer Ingelheim, joined Strategic Intent to talk about leading one of the company's most ambitious US launch periods in…
- Drug Fix: Lessons From US FDA Commissioner Nominee Heidi Overton’s Confirmation Hearing · 30 minPink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs dissect US Food and Drug Administration…
- Assessing the current dealmaking environment for psychedelic medicine. · 20 minJoseph Haas and Emma Wille overview the dealmaking environment for psychedelic medicine given recent developments in the space: Eli Lilly's $2.8 billion acquisition of…
- Strategic Intent: Rubedo’s Seno-Adaptive Bet On Longevity Medicine · 40 minIn this episode of Strategic Intent, In Vivo senior reporter David Wild speaks with Frederick Beddingfield, CEO of Rubedo Life Sciences, about turning the biology of aging into…
- Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection · 21 minIn this month: Marion Webb highlights Oura’s IPO, new partnerships, and a class-action lawsuit. George Underwood discusses digital tools for early Alzheimer’s detection and Brian…
- Strategic Intent: Next‑Generation Cancer Vaccines And Nouscom’s Strategy For Interception And Personalization · 36 min"Personalized and off‑the‑shelf cancer vaccines are moving from concept to clinic, raising new questions about differentiation, manufacturability, and commercial value. In this…
- Scaling Self-Care In Asia Pacific, With APSMI's Rachmadi Joesoef and Anama O'Reilly · 37 minIn this episode of Over the Counter, now also in video, HBW Insight talks to Rachmadi Joesoef, APSMI chair and CEO of Indonesian manufacturer PT Konimex, and Anama O'Reilly, who…
- Drug Fix: Increasing US FDA Leadership Stability And Where All The Adcomms Have Gone · 36 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and Prevision Policy Founding Member Mike McCaughan consider the impact of…
- Strategic Intent: Evolving Requirements Of Life Sciences Leadership · 21 minIn this episode of Strategic Intent, Nick Stephens, chairman of the recruitment and executive placement company RSA group, looks at the state of executive leadership across the…
- Drug Fix: US FDA Commissioner Nominee Heidi Overton’s Resume And COVID-19 Vaccine Trial Changes · 38 minPink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman, and Editor-in-Chief Nielsen Hobbs discuss Heidi Overton’s financial and…
- Proof Of Concept: How A Charity Bridges Lab And Clinic · 21 minCancer Research UK is best known for funding science. But its commercial arm, Cancer Research Horizons, does something less obvious: it builds companies. This episode features…
- Off-Patent, On Record: A Story Of Patients Fighting For Accessible Cystic Fibrosis Treatment · 23 minIn the second episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė hears how patients with cystic fibrosis travelled to Bangladesh to collect…
- Strategic Intent: Beyond The Breakthrough - From Approval To Adoption · 40 minA medical device can work beautifully and still go nowhere. In this episode of Strategic Intent, Krishna Eluri sits down with Mark Saxton, U.S. CEO of Baird Medical, who has…
- Making The Case For Switch, With AESGP’s Christelle Anquez-Traxler · 28 minProducts like ibuprofen and loratadine are now grabbed off a pharmacy shelf without a second thought, but both started out as prescription-only medicines. The process that moves…
- ZS On How AI is Reshaping The Patient's Approach to Care Delivery - a View From the US, China and Germany · 36 minA landmark three-country survey by the ZS consulting and technology firm , which shows the rapid trend towards patients' uptake of AI tools that empower them on their healthcare…
- Drug Fix: MFN Finds Mid-Size Companies And More Vaccine Policy Moves · 30 minPink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the potential differences between…
- 【3分で解説 #世界のファーマ】第30回 米国、ジェネリック関税に国内外から懸念/BMSとAZ合併の噂 (Japanese-language podcast) Aug. 28, 2026 · 4 min世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら. As US Threatens A Tariff Bomb On Generic Drugs, Will…
- Videocast: Goodwin’s Sophie McGrath – A Legal View Of Healthtech And Biopharma Trends · 41 minA videocast for the In Vivo podcast section, with Goodwin's Sophie McGrath - talking about healthtech and pharma trends. Innovation, investment, legal, Goodwin, Sophie McGrath…
- Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency · 30 minPink Sheet Editor-in-Chief Nielsen Hobbs, executive editor Derrick Gingery, and senior reporter Maaisha Osman discuss new FDA commissioner nominee Heidi Overton, her prospects…
- Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment · 33 minOne in ten women has endometriosis, yet treatment options remain largely unchanged for decades. Tanya Petrossian, CEO of EndoCyclic Therapeutics, explains how her company's…
- Strategic Intent: The Rise Of Mid-Cap Dealmakers · 16 minBiopharma’s small-to-mid-cap players are stepping up as serious acquirers. David Wild and Scrip’s Jessica Merrill unpack how companies like argenx, Insmed, Jazz, Genmab, UCB, and…
- Building The GLP-1 Companion Category, With Beverley Law And Martina Gripp · 48 minEveryone in consumer health is talking about GLP-1s. While this new generation of weight loss drugs is firmly on the prescription-only side, industry is now thinking about how it…








